Abstract
Patients being treated for atrial fibrillation may develop cardiovascular disease before or after the onset of their heart rhythm problem, and may require a combination of antiplatelet and anticoagulant drugs. This article describes the evidence for the combinations used to treat acute coronary syndrome in patients with atrial fibrillation.
Original language | English |
---|---|
Journal | British journal of hospital medicine (London, England : 2005) |
Volume | 76 |
Issue number | 11 |
DOIs | |
Publication status | Published - 2 Nov 2015 |